Additionally, accumulating evidence has suggested that SDF-1α plays a role in ischemic preconditioning of the cardiac tissue, which is known to be associated with the reduction of infarct size in patients with myocardial infarction [34] and with better clinical outcomes in patients following PCI and cardiac surgery [19, 35–37]. Here, CXCL12 is linked to myocardial infarction.